| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.038 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |